Covid, Iss: strong reduction in cases 12-19 years, is the vaccine effect
2021-09-27T01:50:27.631Z
Against the increase in the incidence of Covid cases detected at the beginning of July in all age groups, starting from the beginning of August there was a "strong decrease" in the incidence in the 12-19 year range and a less marked decrease in incidence in the over 20s. For the population under the age of 12, who do not have access to vaccination, the incidence began to decrease only from the end of August together with the reduction in overall cases. This was reported in the extended ISS report updated to 22 September. Since the beginning of the epidemic at 12 noon on 22 September 2021, there have been 748,615 confirmed cases of COVID-19 in the population aged 0-19, of which 34 have died. During the period 6 - 19 September 2021 14 were diagnosed and reported.967 new cases in the population 0-19 years, of which 151 hospitalized, 2 hospitalized in intensive care and no deaths (the reported values do not include people hospitalized, hospitalized in intensive care and who died diagnosed before September 6). In the previous two weeks (23 August - 5 September 2021) 21,036 new cases were diagnosed in the population 0-19 years, of which 246 hospitalized, 2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.of which 151 hospitalized, 2 hospitalized in intensive care and no deaths (the reported values do not include people hospitalized, hospitalized in intensive care and who died diagnosed before September 6). In the previous two weeks (23 August - 5 September 2021) 21,036 new cases were diagnosed in the population 0-19 years, of which 246 hospitalized, 2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.of which 151 hospitalized, 2 hospitalized in intensive care and no deaths (the reported values do not include people hospitalized, hospitalized in intensive care and who died diagnosed before September 6). In the previous two weeks (23 August - 5 September 2021) 21,036 new cases were diagnosed in the population 0-19 years, of which 246 hospitalized, 2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.2 admitted to intensive care and no deaths (reported values do not include people hospitalized, admitted to intensive care and who died diagnosed before September 6). In the previous two weeks (23 August - 5 September 2021) 21,036 new cases were diagnosed in the population 0-19 years, of which 246 hospitalized, 2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.2 admitted to intensive care and no deaths (reported values do not include people hospitalized, admitted to intensive care and who died diagnosed before September 6). In the previous two weeks (23 August - 5 September 2021) 21,036 new cases were diagnosed in the population 0-19 years, of which 246 hospitalized, 2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.admitted to intensive care and died diagnosed before September 6). In the previous two weeks (23 August - 5 September 2021) 21,036 new cases were diagnosed in the population 0-19 years, of which 246 hospitalized, 2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.admitted to intensive care and died diagnosed before September 6). In the previous two weeks (23 August - 5 September 2021) 21,036 new cases were diagnosed in the population 0-19 years, of which 246 hospitalized, 2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.2 hospitalized in intensive care and 1 deceased. From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups. Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.
Circular Ministry of Health, yes vaccine in pregnancy and lactation
Pfizer-BioNTech: safe vaccine for children between 5 and 11 years
Third dose of anti-Covid vaccine, here are the 10 categories for which it is foreseen
Share
September 25, 2021 In the face of the growth in the incidence of Covid cases detected at the beginning of July in all age groups, starting from the beginning of August there was a "sharp decrease" in the incidence in the 12-19 age group and a decrease less marked incidence in the over 20s. For the population under the age of 12, who do not have access to vaccination, the incidence began to decrease only from the end of August together with the reduction in overall cases.
This was reported in the extended ISS report updated to 22 September.
Since the beginning of the epidemic at 12 noon on 22 September 2021, there have been 748,615 confirmed cases of COVID-19 in the population aged 0-19, of which 34 have died. During the period 6 - 19 September 2021, 14,967 new cases were diagnosed and reported in the population 0-19 years, of which 151 hospitalized, 2 hospitalized in intensive care and no deaths (the reported values do not include hospitalized persons, hospitalized in intensive care and deaths diagnosed before September 6).
In the previous two weeks (23 August - 5 September 2021) 21,036 new cases were diagnosed in the population 0-19 years, of which 246 hospitalized, 2 hospitalized in intensive care and 1 deceased.
From the second decade of July there was an increase in the percentage of cases in the younger age groups (under 3, 3-5, 6-11) to the detriment of the 12-15 and 16-19 age groups.
Although the data is not consolidated, in the last two weeks more than 50% of cases diagnosed in the age group 0-19 years have been observed in subjects younger than 12 years.
